Having trouble finding a Sector – Health fund? Janus Henderson Global Life Science A (JFNAX) is a potential starting point. JFNAX carries a Zacks Mutual Fund Rank of 1 (Strong Buy), which is based on various forecasting factors like size, cost, and past performance.

Bạn đang xem: Is Janus Henderson Global Life Science A (JFNAX) a Strong Mutual Fund Pick Right Now?

Zacks categorizes JFNAX as Sector – Health, a segment packed with options. Sector – Health mutual funds offer investors a focus on the healthcare industry, one of the largest sectors in the American economy. These funds can include everything from pharmaceutical companies to medical device manufacturers and for-profit hospitals.

JFNAX finds itself in the Janus Fund family, based out of Boston, MA. Since Janus Henderson Global Life Science A made its debut in July of 2009, JFNAX has garnered more than $288.39 million in assets. Andy Acker is the fund’s current manager and has held that role since July of 2009.

Investors naturally seek funds with strong performance. This fund in particular has delivered a 5-year annualized total return of 10.14%, and is in the top third among its category peers. If you’re interested in shorter time frames, do not dismiss looking at the fund’s 3 -year annualized total return of 7.56%, which places it in the top third during this time-frame.

It is important to note that the product’s returns may not reflect all its expenses. Any fees not reflected would lower the returns. Total returns do not reflect the fund’s [%] sale charge. If sales charges were included, total returns would have been lower.

Xem thêm : Is John Hancock2 Capital Appreciation 1 (JICPX) a Strong Mutual Fund Pick Right Now?

When looking at a fund’s performance, it is also important to note the standard deviation of the returns. The lower the standard deviation, the less volatility the fund experiences. The standard deviation of JFNAX over the past three years is 14.86% compared to the category average of 14.64%. Over the past 5 years, the standard deviation of the fund is 15.59% compared to the category average of 15.54%. This makes the fund more volatile than its peers over the past half-decade.

Investors should note that the fund has a 5-year beta of 0.69, so it is likely going to be less volatile than the market at large. Alpha is an additional metric to take into consideration, since it represents a portfolio’s performance on a risk-adjusted basis relative to a benchmark, which in this case, is the S&P 500. JFNAX’s 5-year performance has produced a negative alpha of -1.18, which means managers in this portfolio find it difficult to pick securities that generate better-than-benchmark returns.

Story Continues